共 15 条
[2]
The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study[J] . Lizao Zhang,Bowen Li,Yu Peng,Fan Wu,Qunxing Li,Zhaoyu Lin,Shule Xie,Liping Xiao,Xinyu Lin,Zhanpeng Ou,Tingting Cai,Haixu Rong,Song Fan,Jinsong Li.Oral Oncology . 2020
[3]
Diagnostic and prognostic biomarkers in cholangiocarcinoma[J] . Macias Rocio I R,Kornek Miroslaw,Rodrigues Pedro M,Paiva Nuno A,Castro Rui E,Urban Sabine,Pereira Stephen P,Cadamuro Massimiliano,Rupp Christian,Loosen Sven H,Luedde Tom,Banales Jesus M.Liver international : official journal of the International Association for the Study of the Liver . 2019 (s1)
[4]
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic[J] . Chan T A,Yarchoan M,Jaffee E,Swanton C,Quezada S A,Stenzinger A,Peters S.Annals of oncology : official journal of the European Society for Medical Oncology . 2019 (1)
[6]
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma
[J].
SCIENTIFIC REPORTS,
2017, 7
[7]
Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma[J] . Sven H. Loosen,Christoph Roderburg,Katja L. Kauertz,Inês Pombeiro,Catherine Leyh,Fabian Benz,Mihael Vucur,Thomas Longerich,Alexander Koch,Till Braunschweig,Tom F. Ulmer,Christoph Heidenhain,Frank Tacke,Marcel Binneb?sel,Maximilian Schmeding,Christian Trautwein,Ulf P. Neumann,Tom Luedde.Journal of Hepatology . 2017
[8]
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden[J] . Chalmers Zachary R,Connelly Caitlin F,Fabrizio David,Gay Laurie,Ali Siraj M,Ennis Riley,Schrock Alexa,Campbell Brittany,Shlien Adam,Chmielecki Juliann,Huang Franklin,He Yuting,Sun James,Tabori Uri,Kennedy Mark,Lieber Daniel S,Roels Steven,White Jared,Otto Geoffrey A,Ross Jeffrey S,Garraway Levi,Miller Vincent A,Stephens Phillip J,Frampton Garrett M.Genome medicine . 2017 (1)
[10]
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise[J] . Saha Supriya K,Zhu Andrew X,Fuchs Charles S,Brooks Gabriel A.The oncologist . 2016 (5)